Breadcrumb

CHAL  |  Cardiovascular Health across the Lifespan Program

Our Researchers

The Cardiovascular Health Across the Lifespan (CHAL) Program brings together seven basic researchers, thirty clinician-scientists and eight health outcomes researchers. Researchers from the Centre for Translational Biology (CTB) conduct basic research projects related to vascular function and related diseases, especially atherosclerosis, hypercholesterolemia and vascular injury. Investigators from the Centre for Innovative Medicine (CIM) focus their research on surgery outcomes and on improving prevention and care in patients affected by such cardiac diseases as heart failure, arrhythmias and valve diseases. Investigators from the Centre for Outcomes Research and Evaluation (CORE) seek to develop networks, databases and new tools to improve population health. These include epidemiological outcome and intervention studies on congenital heart disease (CHD), and different factors (genetic, environmental, gender-based) for cardiovascular diseases. CHAL researchers are based at the Glen site, at the heritage site of the Royal Victoria Hospital of the MUHC and at 5252 de Maisonneuve Boulevard W.

Filters icon icon

Displaying 63 result(s).

Michal Abrahamowicz, PhD

biostatistics

cohort studies

comparative effectiveness

confounding

instrumental variables

CORE

Mariane Bertagnolli, PhD, M.Sc., B.Sc.(PT)

angiogenesis

pre-eclampsia

hypertension

cardiac rehabilitation

women's health

CTB

Amal Bessissow, MD, M.Sc., FRCPC

perioperative medicine

cardiovascular outcomes

six-minute walk test

CORE

James Brophy, MD, PhD

cardiovascular epidemiology

pharmacoepideiology

Bayesian statistics

CORE

Renzo Cecere, MD

Heart failure

heart assist devices

mitral valve

stem cells

medical device design

CTB

Dominic Chalut, MD

asthma

toxicology

quality assurance

trauma

pediatric emergency medicine

Robert Côté, MD

stroke

stroke prevention

acute management

clinical research

Stella Daskalopoulou, MD, M.Sc., DIC, PhD

atherosclerosis

vascular biology

arterial stiffness and vessel hemodynamics

hypertension

cardiovascular risk factors

CTB

Natalie Dayan, MD, M.Sc., FRCPC

epidemiology

clinical research

women's health

pregnancy

maternal health

CORE

James Engert, PhD

genetic association studies

single-nucleotide polymorphisms (SNPs)

gene-environment interactions

atherosclerosis

aortic stenosis

CTB

Vidal Essebag, MD, PhD

Epidemiology

statistical analysis

methodology

database analysis

data management

Matthias Friedrich, MD, FESC, FACC

Cardiovascular magnetic resonance

myocardial ischemia

coronary heart disease

acute myocardial infarction

myocarditis

CTB

Jacques Genest, MD, FRCP(C)

lipoproteins

high-density lipoprotein (HDL)

familial hypercholesterolemia

genetics

ABCA1

CTB

Nadia Giannetti, MD

heart attack

défaillance cardiaque

heart transplantation

greffe cardiaque

cardiomyopathy

Mark Goldberg, B.Sc., M.Sc., PhD

epidemiology

environment

occupation

cancer

cardiorespiratory diseases

CORE

Ronald Gottesman, MD

Simulation

medical education

clinical trials

expert systems

Thao Huynh, MD, PhD

cardiovascular

sex and gender

ethnicity

knowledge translation

guidelines

Robert Kiss, PhD

cholesterol

intracellular trafficking

cell biology

microscopy

CTB

Kevin Lachapelle, MD

Marrow stromal cells

angiogenesis

revascularization

Ilka Lowensteyn, PhD

Cardiac rehabilitation

exercise physiology

kinesiology

prevention

wellness

Judy Luu, MD, PhD

women's heart health

cardiac MRI

ischemic heart disease

healthcare disparities

equity/diversity/inclusion

CORE

Sheldon Magder, MD

Vascular biology

endothelial function

nitric oxide

estrogen

oxygen radicals

Isabelle Malhamé, MD, M.Sc., FRCPC

pregnancy

postpartum

severe maternal morbidity

maternal mortality

preeclampsia

CORE

Ariane Marelli, MD, MPH, FRCPC, FACC, FAHA

health services

epidemiology

congenital heart disease

cardiovascular

cardiology

CORE

Thomas Mavrakanas, MD, M.Sc.

chronic kidney disease

kidney failure

cardiovascular disease

anticoagulation

cardiorenal syndromes

CORE

David Mulder, MD

General thoracic surgery

lung cancer

thoracic trauma

airway injury

sports medicine

Nicolo Piazza, MD, PhD, FRCO(C), FESC

Aortic Valve

mitral Valve

transcatheter valves

transcatheter aortic valve implantation

transcatheter aortic valve replacement

Louise Pilote, MD, MPH, PhD, FRCPC

comparative effectivenesse

sex differences in cardiovascular diseases

outcomes research

cardiovascular epidemiology

pharmacoepidemiology

CORE

Marc Rodger, MD, M.Sc.

Venous thrombosis

pulmonary embolism

pregnancy

anticoagulation

diagnosis

CORE

Adel Schwertani, DM, PhD

cardiology

heart

vasoactive substances

atherosclerosis

pulmonary hypertension

CTB

Sam Shemie, MD

brain death

neurological determination of death

organ donation

organ donor management

pediatric

Dominique Shum-Tim, MD, M.Sc.

Pediatric cardiac surgery

cardiopulmonary bypass

hypothermia

circulatory arrest

systemic inflammatory response

Allan Sniderman, MD

prevention

cardiovascular

disease

atherosclerosis

apoB

CORE

Oren Steinmetz, MD

aneurysm

carotid stenosis

endovascular

Robyn Tamblyn, MScN, M.Sc., PhD, CM

health services

medical education

medical informatics

practice changes

pharmacoepidemiology

CORE

George Thanassoulis, MD

Genetics

genomics

cardiovascular disease

aortic stenosis

myocardial infarction

CORE

Rhian Touyz, MBBCh, M.Sc. (Med), PhD

hypertension

obesity

cardiovascular risk factors

small vessel disease

vascular biology

CTB

Charlotte Usselman, PhD

blood pressure regulation

cardiovascular health

gender

gonadal hormones

human integrative physiology

Atul Verma, MD FRCPC FHRS

arrhythmias

atrial fibrillation

ventricular tachycardia

catheter ablation

novel pacing techniques

CORE

Explore what the CHAL Program has to offer